190 related articles for article (PubMed ID: 37546562)
41. Plasma Exosomal Long Non-Coding RNAs Serve as Biomarkers for Early Detection of Colorectal Cancer.
Hu D; Zhan Y; Zhu K; Bai M; Han J; Si Y; Zhang H; Kong D
Cell Physiol Biochem; 2018; 51(6):2704-2715. PubMed ID: 30562751
[TBL] [Abstract][Full Text] [Related]
42. Identification of circ_0000375 and circ_0011536 as novel diagnostic biomarkers of colorectal cancer.
Yin TF; Du SY; Zhao DY; Sun XZ; Zhou YC; Wang QQ; Zhou GY; Yao SK
World J Clin Cases; 2022 Apr; 10(11):3352-3368. PubMed ID: 35611198
[TBL] [Abstract][Full Text] [Related]
43. Identification of Diagnostic Exosomal LncRNA-miRNA-mRNA Biomarkers in Colorectal Cancer Based on the ceRNA Network.
Zhao Y; Song X; Song X; Xie L
Pathol Oncol Res; 2022; 28():1610493. PubMed ID: 36185995
[No Abstract] [Full Text] [Related]
44. Identification of exosomal hsa-miR-483-5p as a potential biomarker for hepatocellular carcinoma via microRNA expression profiling of tumor-derived exosomes.
Lin J; Lin W; Bai Y; Liao Y; Lin Q; Chen L; Wu Y
Exp Cell Res; 2022 Aug; 417(2):113232. PubMed ID: 35659970
[TBL] [Abstract][Full Text] [Related]
45. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion.
Liu L; Meng T; Yang XH; Sayim P; Lei C; Jin B; Ge L; Wang HJ
Cancer Biomark; 2018; 22(2):283-299. PubMed ID: 29630521
[TBL] [Abstract][Full Text] [Related]
46. Tumor cells-derived exosomal circVCP promoted the progression of colorectal cancer by regulating macrophage M1/M2 polarization.
Tang Y; Hu S; Li T; Qiu X
Gene; 2023 Jun; 870():147413. PubMed ID: 37028610
[TBL] [Abstract][Full Text] [Related]
47. Hypoxia-Inducible Exosomes Facilitate Liver-Tropic Premetastatic Niche in Colorectal Cancer.
Sun H; Meng Q; Shi C; Yang H; Li X; Wu S; Familiari G; Relucenti M; Aschner M; Wang X; Chen R
Hepatology; 2021 Nov; 74(5):2633-2651. PubMed ID: 34110633
[TBL] [Abstract][Full Text] [Related]
48. Serum long non‑coding RNA NNT‑AS1 protected by exosome is a potential biomarker and functions as an oncogene via the miR‑496/RAP2C axis in colorectal cancer.
Yin H; Hu J; Ye Z; Chen S; Chen Y
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34132374
[TBL] [Abstract][Full Text] [Related]
49. Exosomal proteins as a source of biomarkers in colon cancer-derived peritoneal carcinomatosis - A pilot study.
Vallejos PA; Fuller RN; Kabagwira J; Kwong ML; Gonda A; McMullen JRW; Le N; Selleck MJ; Miller LD; Perry CC; Senthil M; Wall NR
Proteomics Clin Appl; 2023 Mar; 17(2):e2100085. PubMed ID: 36217952
[TBL] [Abstract][Full Text] [Related]
50. Plasma exosomal proteomic studies of corneal epithelial injury in diabetic and non-diabetic group.
Chen K; Sheng M; Zhang J; Yan G; Li B
Exp Eye Res; 2021 Nov; 212():108794. PubMed ID: 34656547
[TBL] [Abstract][Full Text] [Related]
51. Mesenchymal Stem Cell-Derived Exosomal microRNA-3940-5p Inhibits Colorectal Cancer Metastasis by Targeting Integrin α6.
Li T; Wan Y; Su Z; Li J; Han M; Zhou C
Dig Dis Sci; 2021 Jun; 66(6):1916-1927. PubMed ID: 32671583
[TBL] [Abstract][Full Text] [Related]
52. The potential of exosomes derived from colorectal cancer as a biomarker.
Xiao Y; Li Y; Yuan Y; Liu B; Pan S; Liu Q; Qi X; Zhou H; Dong W; Jia L
Clin Chim Acta; 2019 Mar; 490():186-193. PubMed ID: 30194933
[TBL] [Abstract][Full Text] [Related]
53. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L
Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356
[TBL] [Abstract][Full Text] [Related]
54. Plasma exosomal protein PLG and SERPINA1 in colorectal cancer diagnosis and coagulation abnormalities.
Li L; Song X; Chen G; Zhang Z; Zheng B; Zhang Q; Wang S; Xie L
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8507-8519. PubMed ID: 37093347
[TBL] [Abstract][Full Text] [Related]
55. Proteomic profiling of circulating plasma exosomes reveals novel biomarkers of Alzheimer's disease.
Cai H; Pang Y; Wang Q; Qin W; Wei C; Li Y; Li T; Li F; Wang Q; Li Y; Wei Y; Jia L
Alzheimers Res Ther; 2022 Dec; 14(1):181. PubMed ID: 36471423
[TBL] [Abstract][Full Text] [Related]
56. Exosomal miR-183-5p promotes angiogenesis in colorectal cancer by regulation of FOXO1.
Shang A; Wang X; Gu C; Liu W; Sun J; Zeng B; Chen C; Ji P; Wu J; Quan W; Yao Y; Wang W; Sun Z; Li D
Aging (Albany NY); 2020 May; 12(9):8352-8371. PubMed ID: 32364530
[TBL] [Abstract][Full Text] [Related]
57. Quantitative proteomic profiling of tumor-associated vascular endothelial cells in colorectal cancer.
Wang G; Yang Q; Li M; Zhang Y; Cai Y; Liang X; Fu Y; Xiao Z; Zhou M; Xie Z; Huang H; Huang Y; Chen Y; He Q; Peng F; Chen Z
Biol Open; 2019 May; 8(5):. PubMed ID: 31036754
[TBL] [Abstract][Full Text] [Related]
58. Integrated analysis of the functions and clinical implications of exosome circRNAs in colorectal cancer.
Lei T; Zhang Y; Wang X; Liu W; Feng W; Song W
Front Immunol; 2022; 13():919014. PubMed ID: 35924235
[TBL] [Abstract][Full Text] [Related]
59. Identification of stage-associated exosome miRNAs in colorectal cancer by improved robust and corroborative approach embedded miRNA-target network.
Long F; Tian L; Chai Z; Li J; Tang Y; Liu M
Front Med (Lausanne); 2022; 9():881788. PubMed ID: 36237545
[TBL] [Abstract][Full Text] [Related]
60. Exosome-encapsulated microRNAs as circulating biomarkers for colorectal cancer.
Yan S; Han B; Gao S; Wang X; Wang Z; Wang F; Zhang J; Xu D; Sun B
Oncotarget; 2017 Sep; 8(36):60149-60158. PubMed ID: 28947960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
